This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Privacy Overview
C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines
Colin A. Bill, Olga B. Soto and Charlotte M. Vines*
C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines
In casual conversation with non-medical individuals, it is common for them to ask:
why do we not have a cure for cancer or vaccinations for all diseases? It seems somewhat
logical to assume that after so many years of research that cures should be readily available,
diseases in general should simply require a pill or jab and that somehow, if scientists are not
deliberately hiding these cures, then they must be asleep at the wheel.
A typical response to such questions focuses on the complexity of the different
cancers/diseases and that there will be no “one cure fits all”.
When it comes to vaccinations, there is absolutely no doubt that
many vaccines are extremely effective and a multitude of publications can attest to this and
cite how many lives have been saved because of our vaccination programs;
indeed, vaccinations typically pop up on a list of reasons why humans
today are living substantially longer than at any previous time in history.
Nevertheless, there is always an overriding and to some extent embarrassing
realization that despite the relative success of vaccines we still
do not, for the most part, know how to make consistently effective vaccines and that often it
boils down to a trial and error procedure to establish the best vaccine for a given target.
Although a discussion of the secondary immune response could take up a substantial review, in this short commentary as an example of one way to potentially boost antibody production, we will focus on a
single chemokine receptor, C-C Chemokine Receptor Seven (CCR7).
Vaccin Res Open J. 2016; 1(1): 7-9. doi: 10.17140/VROJ-1-102
LATEST ARTICLES
Systematic Review
2023 May
An Update on the Etiopathogenesis of NAFLD including Organokines for Early Diagnosis and Improvement of Management and Preventing Early HCC Development: A Narrative Review
COVID-19 Pandemic, review
2023 May
Mind in Crisis: Examining the Cognitive Consequences of the COVID-19 Pandemic
Retrospective Study
2023 May
Prevalence, Associated Factors and Management of Neonatal Jaundice by Midwives and Nurses of Selected Health Facilities in Fako Division, Cameroon